CyberKnife Stereotactic Ablative Radiotherapy for Lung Tumors

被引：41

作者：

Gibbs, Iris C. ^{[1
]}

Loo, Billy W., Jr.

机构：

[1] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA

来源：

TECHNOLOGY IN CANCER RESEARCH & TREATMENT | 2010年 / 9卷 / 06期

关键词：

Lung cancer; Stereotactic ablative radiotherapy (SABR); Stereotactic body radiotherapy (SBRT); Radiosurgery; CyberKnife; BODY RADIATION-THERAPY; RADIOSURGERY; CANCER; TRACKING; PLACEMENT; ACCURACY; NEOPLASM;

D O I：

10.1177/153303461000900607

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Stereotactic ablative radiotherapy (SABR) has emerged as a promising treatment for early stage non-small cell lung cancer, particularly for patients unable to tolerate surgical resection. High rates of local tumor control have been demonstrated with acceptable toxicity and the practical advantage of a short course of treatment. The CyberKnife image-guided robotic radiosurgery system has unique technical characteristics that make it well suited for SABR of tumors that move with breathing, including lung tumors. We review the qualities of the CyberKnife platform for lung tumor SABR, and provide a summary of clinical data using this system specifically.

引用

页码：589 / 596

页数：8

共 50 条

[41] Immunomodulatory effect of stereotactic ablative radiotherapy in lung cancer
Domagala-Kulawik, Joanna
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (04): : 233 - 234
[42] Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer
Abbas, Ghulam
Danish, Adnan
Krasna, Mark J.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 553 - +
[43] Stereotactic ablative radiotherapy with CyberKnife in the treatment of locally advanced prostate cancer: preliminary results
Fan, Chao-Yueh
Chao, Hsing-Lung
Huang, Wen-Yen
Lin, Chun-Shu
Chen, Chang-Ming
Lo, Cheng-Hsiang
TUMORI JOURNAL, 2015, 101 (06): : 684 - 691
[44] Organizing pneumonia after stereotactic ablative radiotherapy of the lung
Taro Murai
Yuta Shibamoto
Takeshi Nishiyama
Fumiya Baba
Akifumi Miyakawa
Shiho Ayakawa
Hiroyuki Ogino
Shinya Otsuka
Hiromitsu Iwata
Radiation Oncology, 7
[45] Evaluation of target coverage in lung stereotactic radiotherapy with Cyberknife system
Ricotti, R.
Seregni, M.
Ciardo, D.
Vigorito, S.
Rondi, E.
Piperno, G.
Zerella, M. A.
Arculeo, S.
Francia, C.
Sibio, D.
Cattani, F.
Orecchia, R.
Riboldi, M.
Baroni, G.
Jereczek-Fossa, B.
RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1107 - S1108
[46] Cyberknife—Stereotactic radiotherapy in oncology
Senger C.
Acker G.
Kluge A.
Stromberger C.
best practice onkologie, 2019, 14 (6) : 238 - 246
[47] Identifying dosimetric predictors of toxicity in multiple lung tumors treated with stereotactic ablative radiotherapy (SABR)
Tekatli, H.
Tetar, S.
Warner, A.
Palma, D.
Verbakel, W.
Nguyen, T.
Spoelstra, F.
Gaede, S.
Slotman, B.
Senan, S.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S143 - S143
[48] Individualized Stereotactic Ablative Radiotherapy for Lung Tumors The iSABR Phase 2 Nonrandomized Controlled Trial
Gensheimer, Michael F.
Gee, Harriet
Shirato, Hiroki
Taguchi, Hiroshi
Snyder, John M.
Chin, Alexander L.
Vitzthum, Lucas K.
Maxim, Peter G.
Wakelee, Heather A.
Neal, Joel
Das, Millie
Chang, Daniel T.
Kidd, Elizabeth
Hancock, Steven L.
Shultz, David B.
Horst, Kathleen C.
Le, Quynh-Thu
Wong, Samantha
Brown, Eleanor
Nguyen, Ngan
Liang, Rachel
Loo, Billy W.
Diehn, Maximilian
JAMA ONCOLOGY, 2023, 9 (11) : 1525 - 1534
[49] Stereotactic ablative radiotherapy for small lung tumors with a moderate dose Favorable results and low toxicity
Duncker-Rohr, V.
Nestle, U.
Momm, F.
Prokic, V.
Heinemann, F.
Mix, M.
Reusch, J.
Messmer, M. -B.
Marschner, N.
Waller, C. F.
Weber, W. A.
Grosu, A. -L.
STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (01) : 33 - 40
[50] Does Histological Subtype Affect Outcomes in Stereotactic Ablative Body Radiotherapy (SABR) for Lung Tumors?
Allos, B.
Mascall, S.
Vreugdenhil, M.
Watkins, S.
Stevenson, R.
Ghafoor, Q.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2179 - S2180

← 1 2 3 4 5 →